Literature DB >> 20386497

The phosphoinositide-3 kinase survival signaling mechanism in sepsis.

Mariuxi C Manukyan1, Brent R Weil, Yue Wang, Aaron M Abarbanell, Jeremy L Herrmann, Jeffrey A Poynter, Daniel R Meldrum.   

Abstract

Phosphoinositide-3 kinases (PI3Ks) are critical regulatory proteins in the immunologic defense system against sepsis. The PI3K mechanism helps modulate cellular survival, innate and adaptive immunities, inflammation, nuclear factor-κB transcription, and may, in turn, play a protective role in sepsis. Animal studies confirm its role in the prevention of organ dysfunction and improvement of survival outcomes. Further advances in the understanding of this key immunomodulatory pathway may provide valuable insights into the manipulation of cellular function for therapeutic treatment of sepsis and other inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20386497     DOI: 10.1097/SHK.0b013e3181e14ea9

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  19 in total

1.  Astragalus polysaccharide attenuates lipopolysaccharide-induced inflammatory responses in microglial cells: regulation of protein kinase B and nuclear factor-κB signaling.

Authors:  Tao Luo; Jian Qin; Min Liu; Jun Luo; Fang Ding; Mingling Wang; Limin Zheng
Journal:  Inflamm Res       Date:  2015-02-11       Impact factor: 4.575

2.  Enhanced liver autophagic activity improves survival of septic mice lacking surfactant proteins A and D.

Authors:  Zhe Tang; Lan Ni; Sara Javidiparsijani; Fengqi Hu; Louis A Gatto; Robert Cooney; Guirong Wang
Journal:  Tohoku J Exp Med       Date:  2013-10       Impact factor: 1.848

3.  Interleukin-7 and anti-programmed cell death 1 antibody have differing effects to reverse sepsis-induced immunosuppression.

Authors:  Yuichiro Shindo; Jacqueline Unsinger; Cary-Ann Burnham; Jonathan M Green; Richard S Hotchkiss
Journal:  Shock       Date:  2015-04       Impact factor: 3.454

Review 4.  Signaling pathways and intervention therapies in sepsis.

Authors:  Yun-Yu Zhang; Bo-Tao Ning
Journal:  Signal Transduct Target Ther       Date:  2021-11-25

5.  Chronic Akt activation attenuated lipopolysaccharide-induced cardiac dysfunction via Akt/GSK3β-dependent inhibition of apoptosis and ER stress.

Authors:  Maolong Dong; Nan Hu; Yinan Hua; Xihui Xu; Machender R Kandadi; Rui Guo; Shasha Jiang; Sreejayan Nair; Dahai Hu; Jun Ren
Journal:  Biochim Biophys Acta       Date:  2013-03-06

6.  17β-estradiol suppresses lipopolysaccharide-induced acute lung injury through PI3K/Akt/SGK1 mediated up-regulation of epithelial sodium channel (ENaC) in vivo and in vitro.

Authors:  Di Qi; Jing He; Daoxin Wang; Wang Deng; Yan Zhao; Yuan Ye; Longhua Feng
Journal:  Respir Res       Date:  2014-12-31

7.  Omentin protects against LPS-induced ARDS through suppressing pulmonary inflammation and promoting endothelial barrier via an Akt/eNOS-dependent mechanism.

Authors:  Di Qi; Xumao Tang; Jing He; Daoxin Wang; Yan Zhao; Wang Deng; Xinyu Deng; Guoqi Zhou; Jing Xia; Xi Zhong; Shenglan Pu
Journal:  Cell Death Dis       Date:  2016-09-08       Impact factor: 8.469

8.  Vaspin protects against LPS‑induced ARDS by inhibiting inflammation, apoptosis and reactive oxygen species generation in pulmonary endothelial cells via the Akt/GSK‑3β pathway.

Authors:  Di Qi; Daoxin Wang; Chunrong Zhang; Xumao Tang; Jing He; Yan Zhao; Wang Deng; Xinyu Deng
Journal:  Int J Mol Med       Date:  2017-10-09       Impact factor: 4.101

9.  Antioxidant and anti-inflammatory effects in RAW264.7 macrophages of malvidin, a major red wine polyphenol.

Authors:  Eszter Bognar; Zsolt Sarszegi; Aliz Szabo; Balazs Debreceni; Nikoletta Kalman; Zsuzsanna Tucsek; Balazs Sumegi; Ferenc Gallyas
Journal:  PLoS One       Date:  2013-06-05       Impact factor: 3.240

10.  Intracellular Networks of the PI3K/AKT and MAPK Pathways for Regulating Toxoplasma gondii-Induced IL-23 and IL-12 Production in Human THP-1 Cells.

Authors:  Juan-Hua Quan; Jia-Qi Chu; Jaeyul Kwon; In-Wook Choi; Hassan Ahmed Hassan Ahmed Ismail; Wei Zhou; Guang-Ho Cha; Yu Zhou; Jae-Min Yuk; Eun-Kyeong Jo; Young-Ha Lee
Journal:  PLoS One       Date:  2015-11-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.